$11.1
Market Capitalization | 87.6M |
Book Value | - $0.4 |
Earnings Per Share (EPS) | 0.19 |
PE Ratio | 56.89 |
Profit Margin | 0.0% |
Operating Margin TTM | 0.0% |
Return On Assets TTM | -1.26% |
Return On Equity TTM | 0.0% |
Revenue TTM | 0.0 |
Revenue Per Share TTM | 0.0 |
Quarterly Revenue Growth YOY | 0.0% |
Gross Profit TTM | 0.0 |
Diluted Eps TTM | 0.19 |
Quarterly Earnings Growth YOY | -0.78 |
EPS Estimate Current Year | 0.0 |
EPS Estimate Next Year | 0.0 |
EPS Estimate Current Quarter | 0.0 |
EPS Estimate Next Quarter | 0.0 |
Sell
Neutral
Buy
Perception Capital Corp Iii is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|
Cable Car Capital LLC
Berkley W R Corp
Quarry LP
Atlas Merchant Capital LLC
Logan Stone Capital, LLC
Westchester Capital Management LLC
Organization | Perception Capital Corp Iii |
Employees | 0 |
CEO | Mr. Richard W. Gaenzle Jr. |
Industry | Miscellaneous |
Virios Therapeutics Inc
$11.10
+0.0%
Lg Qraft Ai-powered Us Large Cap Core Etf
$11.10
+0.0%
Spdr Ftse International Gove
$11.10
+0.0%
John Hancock Investors Closed Fund
$11.10
+0.0%
Proshares Ultra High Yield
$11.10
+0.0%
Lichen China Ltd
$11.10
+0.0%
Arbutus Biopharma Corporation
$11.10
+0.0%
Eaton Vance Enh Eqt Inc Ii
$11.10
+0.0%
Western Asset Diversified Income Fund
$11.10
+0.0%